BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 29, Issue 20
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (8132)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.
Item 
Count 
PDF236
WORD57
HTML4453
Figures (1-3)765
Tables (1-4)634
 Sum=6145
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse314
Download1333
 Sum=1647
May 28, 2023 (publication date) through Mar 12, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Yu J, Lv YM, Yang P, Jiang YZ, Qin XR, Wang XY. Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection. World J Gastroenterol 2023; 29(20): 3133-3144 [PMID: 37346155 DOI: 10.3748/wjg.v29.i20.3133]
URL: https://www.wjgnet.com/1007-9327/full/v29/i20/3133.htm
Number Citing Articles
1
Valerie Josephine Dirjayanto, Jessica Audrey, Daniel Martin Simadibrata. Vonoprazan-amoxicillin dual regimen with <i>Saccharomyces boulardii</i> as a rescue therapy for <i>Helicobacter pylori</i>: Current perspectives and implications. World Journal of Gastroenterology 2024; 30(10): 1280-1286 doi: 10.3748/wjg.v30.i10.1280
2
Yu Huang, Jin-Nan Chen, Shu-Han Qiu, Yi-Xian Guo, Mei-Xuan Li, Ya-Nan Gao, Xiao Liang, Yue-Hua Han, Ping Xu, Jing Wang, Hong Lu. Vonoprazan-amoxicillin dual, rifabutin-based triple, and bismuth quadruple therapies for Helicobacter pylori rescue treatment: a multicentre, open-label, non-inferiority randomised trial. The Lancet Regional Health - Western Pacific 2026; 68: 101815 doi: 10.1016/j.lanwpc.2026.101815
3
Qingsong Qu, Wanhong Zhu, Xingjian Song, Jingqi Zeng, Jie Lin, Xia Ding. From Eradication to Holistic Regeneration: Pharmaceutics Strategies for Reshaping Gastric Homeostasis Against H. pylori Infection. Pharmaceutics 2026; 18(3): 337 doi: 10.3390/pharmaceutics18030337
4
Jie Zhang, Xin Cao, Kai Ma, Yizhou Jiang, Xiangrong Qin, Xiaoyong Wang. Safety and effectiveness of dual therapy for Helicobacter pylori infection and the effect on the glycated hemoglobin level in type 2 diabetes. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-85628-5
5
Ju Zhang, Xinzhao Wang, Shujie Song, Xiaoming Zhu, Ting Lv, Lingling Wang, Lei Lei, Yuhui Wang, Yali Lei, Yating Wang, Xiaojing Zhu, Lifeng Zhang, Min Chen, Yongquan Shi. Efficacy and Safety of Vonoprazan and High‐Dose Amoxicillin Dual Therapy for Rescue Treatment of Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial. United European Gastroenterology Journal 2025; 13(8): 1541 doi: 10.1002/ueg2.70070
6
Weiwei Wang, Lei Wang, Qingqing Fan, Jingyan Xu, Yifan Li, Jiale Xu, Bei Zhao, Dan Ge, Longying Xiong, Yanping Wu, Yun Zhu, Min Chen. Macrophage Membrane-Coated Liposomes Delivering Vonoprazan Disrupt Mitochondrial Oxidative Phosphorylation in Diffuse Large B-Cell Lymphoma. International Journal of Nanomedicine 2025; : 8063 doi: 10.2147/IJN.S520567
7
Karolina Kornatowska, Edyta Hańczyk, Dawid Piecuch, Szymon Kopciał, Natalia Pawelec, Weronika Mazur, Mateusz Tyniec, Kamal Morshed. A Novel Approach to H. pylori Eradication: A Narrative Review of Vonoprazan-Based Therapies. Gastroenterology Insights 2025; 16(3): 35 doi: 10.3390/gastroent16030035
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345